4PES
Crystal structure of insulin degrading enzyme complexed with inhibitor tert-butyl [(2S)-2-(2,5-difluorophenyl)-3-(quinolin-3-yl)propyl]carbamate
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-10-12 |
Detector | RAYONIX MX225HE |
Wavelength(s) | 0.97931 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 78.754, 116.087, 123.923 |
Unit cell angles | 90.00, 98.09, 90.00 |
Refinement procedure
Resolution | 122.690 - 2.210 |
R-factor | 0.20926 |
Rwork | 0.209 |
R-free | 0.25606 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2g47 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.331 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.6.0117) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 122.690 | |
High resolution limit [Å] | 2.200 | 2.200 |
Number of reflections | 119894 | |
<I/σ(I)> | 7.9 | |
Completeness [%] | 98.8 | |
Redundancy | 3.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 298 | 20% PEG3350, 0.2 mM sodium thiocyanate |